(M) Macy’s - Overview
Sector: Consumer Cyclical | Industry: Department Stores | Exchange: NYSE (USA) | Market Cap: 5.829m USD | Total Return: 89.2% in 12m
Avg Turnover: 123M
EPS Trend: -85.9%
Qual. Beats: 1
Rev. Trend: -96.3%
Qual. Beats: 6
Warnings
Below Avwap Earnings
Tailwinds
Rs Leader, Idiosyncratic Leader, Tailwind, Pullback 52w
Macy’s, Inc. (M) is a New York-based omni-channel retailer operating under the Macy’s, Bloomingdale’s, and Bluemercury brands. The company maintains a diverse physical and digital footprint, selling apparel, cosmetics, and home furnishings across the United States and through international licensed agreements in the Middle East. As a constituent of the Broadline Retail sub-industry, the company utilizes a multi-tier branding strategy to capture different consumer segments, ranging from mass-market department store shoppers to luxury and specialty beauty clientele.
The department store sector is currently characterized by a shift toward integrated inventory management, where physical locations serve as both showrooms and fulfillment centers for e-commerce orders. Macys business model relies on high-volume seasonal inventory turnover and private-label brand exclusivity to differentiate its product assortment from pure-play digital competitors. Investors may find it useful to evaluate Macys underlying asset value and dividend history on ValueRay. Founded in 1830, the organization has transitioned from its origins as Federated Department Stores to its current structure as a consolidated retail platform.
- Asset monetization and real estate portfolio valuation influence long-term shareholder equity
- High interest rates and inflation pressure discretionary consumer spending on apparel
- Digital sales penetration and omnichannel fulfillment costs impact operating margins
- Inventory management and promotional pricing strategies dictate quarterly gross margin performance
- Luxury segment resilience at Bloomingdales and Bluemercury offsets core brand weakness
| Net Income: 667.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA 6.92 > 1.0 |
| NWC/Revenue: 9.78% < 20% (prev 8.35%; Δ 1.43% < -1%) |
| CFO/TA 0.11 > 3% & CFO 1.79b > Net Income 667.0m |
| Net Debt (6.49b) to EBITDA (1.90b): 3.42 < 3 |
| Current Ratio: 1.48 > 1.5 & < 3 |
| Outstanding Shares: last quarter (272.7m) vs 12m ago -2.85% < -2% |
| Gross Margin: 36.54% > 18% (prev 40.40%; Δ -3.86% > 0.5%) |
| Asset Turnover: 140.3% > 50% (prev 141.7%; Δ -1.44% > 0%) |
| Interest Coverage Ratio: 10.68 > 6 (EBIT TTM 1.01b / Interest Expense TTM 95.0m) |
| A: 0.14 (Total Current Assets 6.90b - Total Current Liabilities 4.67b) / Total Assets 16.3b |
| B: 0.40 (Retained Earnings 6.49b / Total Assets 16.3b) |
| C: 0.06 (EBIT TTM 1.01b / Avg Total Assets 16.2b) |
| D: 0.42 (Book Value of Equity 4.84b / Total Liabilities 11.5b) |
| Altman-Z'' = 3.05 = A |
| DSRI: 1.21 (Receivables 302.0m/251.0m, Revenue 22.7b/22.8b) |
| GMI: 1.11 (GM 40.40% / 36.54%) |
| AQI: 1.02 (AQ_t 0.16 / AQ_t-1 0.16) |
| SGI: 1.00 (Revenue 22.7b / 22.8b) |
| TATA: -0.07 (NI 667.0m - CFO 1.79b) / TA 16.3b) |
| Beneish M = -2.76 (Cap -4..+1) = A |
As of June 08, 2026, the stock is trading at USD 22.16 with a total of 6,463,067 shares traded.
Over the past week, the price has changed by +1.84%,
over one month by +15.24%,
over three months by +24.64% and
over the past year by +89.23%.
Macy’s has received a consensus analysts rating of 3.08. Therefore, it is recommended to hold M.
- StrongBuy: 1
- Buy: 1
- Hold: 9
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 21.5 | -3% |
P/E Trailing = 9.157
P/E Forward = 10.4493
P/S = 0.2566
P/B = 1.2051
P/EG = 3.8149
Revenue TTM = 22.7b USD
EBIT TTM = 1.01b USD
EBITDA TTM = 1.90b USD
Long Term Debt = 2.43b USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 7.79b USD (from shortLongTermDebtTotal, last quarter) + Leases 2.68b
Net Debt = 6.49b USD (calculated: Debt 7.79b - CCE 1.29b)
Enterprise Value = 12.3b USD (5.83b + Debt 7.79b - CCE 1.29b)
Interest Coverage Ratio = 10.68 (Ebit TTM 1.01b / Interest Expense TTM 95.0m)
EV/FCF = 8.20x (Enterprise Value 12.3b / FCF TTM 1.50b)
FCF Yield = 12.19% (FCF TTM 1.50b / Enterprise Value 12.3b)
FCF Margin = 6.61% (FCF TTM 1.50b / Revenue TTM 22.7b)
Net Margin = 2.94% (Net Income TTM 667.0m / Revenue TTM 22.7b)
Gross Margin = 36.54% ((Revenue TTM 22.7b - Cost of Revenue TTM 14.4b) / Revenue TTM)
Gross Margin QoQ = 41.54% (prev 26.68%)
Tobins Q-Ratio = 0.76 (Enterprise Value 12.3b / Total Assets 16.3b)
Interest Expense / Debt = 1.22% (Interest Expense 95.0m / Debt 7.79b)
Taxrate = 23.68% (207.0m / 874.0m)
NOPAT = 774.6m (EBIT 1.01b * (1 - 23.68%))
Current Ratio = 1.48 (Total Current Assets 6.90b / Total Current Liabilities 4.67b)
Debt / Equity = 1.61 (Debt 7.79b / totalStockholderEquity, last quarter 4.84b)
Debt / EBITDA = 3.42 (Net Debt 6.49b / EBITDA 1.90b)
Debt / FCF = 4.32 (Net Debt 6.49b / FCF TTM 1.50b)
Total Stockholder Equity = 4.62b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.12% (Net Income 667.0m / Total Assets 16.3b)
RoE = 14.44% (Net Income TTM 667.0m / Total Stockholder Equity 4.62b)
RoCE = 14.40% (EBIT 1.01b / Capital Employed (Equity 4.62b + L.T.Debt 2.43b))
RoIC = 7.38% (NOPAT 774.6m / Invested Capital 10.5b)
WACC = 4.81% (E(5.83b)/V(13.6b) * Re(9.99%) + D(7.79b)/V(13.6b) * Rd(1.22%) * (1-Tc(0.24)))
Discount Rate = 9.99% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -42.22 | Cagr: -0.37%
[DCF] Terminal Value 77.97% ; FCFF base≈1.05b ; Y1≈1.20b ; Y5≈1.77b
[DCF] Fair Price = 76.55 (EV 26.6b - Net Debt 6.49b = Equity 20.1b / Shares 263.0m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -85.93 | EPS CAGR: -15.54% | SUE: 1.02 | # QB: 1
Revenue Correlation: -96.32 | Revenue CAGR: -2.78% | SUE: 0.85 | # QB: 6
EPS current Quarter (2026-07-31): EPS=0.34 | Chg30d=-1.89% | Revisions=+20% | Analysts=11
EPS next Quarter (2026-10-31): EPS=-0.07 | Chg30d=N/A | Revisions=+20% | Analysts=11
EPS current Year (2027-01-31): EPS=2.16 | Chg30d=+3.14% | Revisions=+20% | GrowthEPS=-6.9% | GrowthRev=-0.5%
EPS next Year (2028-01-31): EPS=2.28 | Chg30d=+3.97% | Revisions=-20% | GrowthEPS=+5.5% | GrowthRev=-1.3%
[Analyst] Revisions Ratio: +20%